| 产品详情 |
| Edit |   |
|---|
| Product Name | BML-210, HDAC Inhibitor (N1-(2-aminophenyl)-N8-phenyloctanediamide) |
|---|
| Description | Purity ~98% (TLC). A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10uM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines. Solubility: DMSO (~25mg/ml) or Ethanol (~10mg/ml, warm) |
|---|
| Size | 5mg, 25mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N1-(2-aminophenyl)-N8-phenyloctanediamide |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 136760 |
|---|
| Price | |
|---|
| Order / More Info | BML-210, HDAC Inhibitor (N1-(2-aminophenyl)-N8-phenyloctanediamide) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|